Abstract
Epithelial ovarian cancer is still the most lethal gynecological
malignancy, with a recurrence rate of 70% in advanced cases. Adi and
compound sophora flavescens have shown potential as antitumor injections
for several cancers. Here, we present a case of advanced epithelial
ovarian cancer treated with Adi combined with compound sophora
flavescens injection for prevention of recurrence and metastasis. The
current survival period of the patient has reached 122 months.
Surprisingly, a durable tumor control has occurred. Although the use of
Aidi in combination with compound matrine injection as a treatment for
ovarian cancer is not fully understood, it has demonstrated satisfactory
clinical efficacy and no significant adverse reactions.
Keyword: Advanced epithelial ovarian cancer; Recurrence and
metastasis; Aidi injection; Compound Sophora flavescens injection